The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Tiziana Life Sciences(NASDAQ:TLSA)
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclona...
Website: http://www.tizianalifesciences.com
Founded: 1998
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology
Tiziana Life Sciences Days Payable Outstanding ttm (DPO)
Tiziana Life Sciences Op Cashflow Per Share ttm
Tiziana Life Sciences Free Cashflow Per Share ttm
Tiziana Life Sciences Cash Per Share ttm
Tiziana Life Sciences (GAAP) P/E ratio ttm
Tiziana Life Sciences P/B ratio ttm
No extra charts and metrics for this ticker.
